Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114123 · ClinicalTrials.gov registry record
The Development of Reward Response to Food in Infancy
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 1,166
- Enrollment target
NCT04114123: Completed study, sponsored by University of Michigan.
NCT04114123 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 1,166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04114123 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 1,166 participants
- Enrollment target
Study Summary
In this study the researchers want to learn more about reward-driven eating behavior in children ages 2 to 18 months. The researchers hope to use this knowledge to help inform obesity prevention programs.
Primary Outcome
Trajectory membership could be "wanting", "salience", or "liking"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,166 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2024-06-19 |
What the finished NCT04114123 record still lists
NCT04114123 is an observational study that tracks outcomes without assigning an intervention. Its 1,166 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04114123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04114123 about?
NCT04114123 is a clinical study titled "The Development of Reward Response to Food in Infancy". In this study the researchers want to learn more about reward-driven eating behavior in children ages 2 to 18 months. The researchers hope to use this knowledge to help inform obesity prevention programs.
What is the current status of trial NCT04114123?
This trial is currently completed. The enrollment target is 1,166 participants. The study started on 2019-11-13. Estimated completion is 2024-06-19.
Who is sponsoring clinical trial NCT04114123?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT04577599 · 1,160 participants · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI